...
首页> 外文期刊>Acta biomaterialia >A polymeric device for controlled transscleral multi-drug delivery to the posterior segment of the eye.
【24h】

A polymeric device for controlled transscleral multi-drug delivery to the posterior segment of the eye.

机译:一种用于控制跨巩膜多药递送至眼后段的聚合物装置。

获取原文
获取原文并翻译 | 示例
           

摘要

The design of drug delivery systems that can deliver multiple drugs to the posterior segment of the eye is a challenging task in retinal disease treatments. We report a polymeric device for multi-drug transscleral delivery at independently controlled release rates. The device comprises a microfabricated reservoir, controlled-release cover and three different fluorescent formulations, which were made of photopolymeized tri(ethyleneglycol)dimethacrylate (TEGDM) and poly(ethyleneglycol)dimethacrylate (PEGDM). The release rate of each fluorescent is controlled by varying the PEGDM/TEGDM ratio in its formulation and the cover. The release kinetics appeared to be related to the swelling ratio of the PEGDM/TEGDM polymers. When the devices were implanted onto rat sclerae, fluorescence was observable in the ocular tissues during 4 weeks' implantation and distributed locally around the implantation site. Our polymeric system, which can administer multiple compounds with distinct kinetics, provides prolonged action and less invasive transscleral administration, and is expected to provide new tools for the treatment of posterior eye diseases with new therapeutic modalities.
机译:在视网膜疾病治疗中,可以将多种药物输送到眼后段的药物输送系统的设计是一项艰巨的任务。我们报告了一种用于独立控制释放速率的多药物跨巩膜递送的聚合物装置。该设备包括一个微型容器,一个控释盖和三种不同的荧光配方,它们由光聚合的三(乙二醇)二甲基丙烯酸酯(TEGDM)和聚(乙二醇)二甲基丙烯酸酯(PEGDM)制成。通过改变其配方和覆盖层中的PEGDM / TEGDM比值,可以控制每种荧光剂的释放速率。释放动力学似乎与PEGDM / TEGDM聚合物的溶胀率有关。当将这些装置植入大鼠巩膜上时,在植入的4周内在眼组织中观察到了荧光,并在植入部位周围局部分布。我们的聚合物系统可以以多种动力学方式给药多种化合物,可提供更长的作用时间和更少的侵入性巩膜给药,并有望以新的治疗方式为治疗后眼疾病提供新的工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号